Malignant cancer is a type of skin cancer that is often seen in people who have had sun damage in the form of sunburns, tanning, or prolonged ultraviolet radiation exposure. It is characterized by uncontrolled growth of abnormal cells in the skin that spread rapidly and can lead to the death of healthy or nearby skin. Malignant skin cancer is the most dangerous type of skin cancer as it has the greatest potential to spread to other areas of the body and become life threatening. It is the deadliest form of the 3 major skin cancers: basal cell carcinoma, squamous cell carcinoma, and malignant melanoma. The primary risk factor for malignant skin cancer is ultraviolet radiation from the sun or tanning beds, although it can also form in areas that have had radiation therapy or long-term exposure to arsenic or industrial chemicals. Certain genetic mutations can also increase the risk of developing this cancer. The most common symptom of malignant skin cancer is the appearance of a growth on the skin that may be raised, scaly, and red or dark in color. Other symptoms may include itching or pain , an ulcer or sore that won’t heal, or changes in mole size. If you suspect you may have malignant skin cancer, it’s important to seek medical attention immediately. Diagnosis must be made promptly as delaying can reduce the chance of recovery or increase the risk of death. After physical examination and biopsy, the doctor can identify the type and grade of the cancer and accurately assess its stage. Once identified, the treatment plan must be tailored according to the stage of the cancer and other factors. Surgery is the most common method of treatment and may be supplemented with radiation, chemotherapy, immunotherapy, or clinical trials. With early diagnosis and prompt treatment, malignant skin cancer can be successfully managed. Although there is no way to completely prevent it, it is important to protect yourself from ultraviolet radiation exposure whenever possible.
Title : Epitomic analysis revealed pemphigus autoantibodies against the ligand-binding pocket of M3 muscarinic acetylcholine receptor
Sergei A Grando, University of California Irvine, United States
Title : Dermatology and cosmetology through art and history of art
Dechelette Corinne, La Peau Autrement, France
Title : The new physiopathology of cellulite
Gustavo Hector Leibaschoff, World Society of Cosmetic Gynecology, United States
Title : A twelve week clinical study testing efficacy and safety of a cosmetic cream with novel actives for uneven skin tone, hyperpigmentation & photoaging
Nalini Kaul, Princeton Consumer Research, Canada
Title : Acne vulgaris and the most popular and new cosmetological treatments
Karolina Chilicka Hebel, University of Opole, Poland
Title : Bioregeneration in aesthetic and functional gynecology
Gustavo Hector Leibaschoff, World Society of Cosmetic Gynecology, United States
Title : Integrating personalized and precision medicine into dermatology clinical practice securing ITS potential to get skin diseases cured and to revolutionize dermatology
Sergey Suchkov, The Russian University for Medicine & The Russian Academy of Natural Sciences, Russian Federation
Title : Perspectives on healthy skin aging and pre-aging concepts
Georgios Stamatas, SGS France, France
Title : The management of FPHL- How it different from male AGA
Rachita Dhurat, LTMMC & LTMG Hospital, India
Title : Tackling stubborn wound by advanced polysaccharides-based biopolymer delivery system
Madhu Gupta, Delhi Pharmaceutical Science and Research University, India